Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Non-cash Items (2022 - 2025)

Historic Non-cash Items for Roivant Sciences (ROIV) over the last 4 years, with Q2 2025 value amounting to $113.0 million.

  • Roivant Sciences' Non-cash Items rose 794.34% to $113.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $113.0 million, marking a year-over-year increase of 794.34%. This contributed to the annual value of $384.0 million for FY2025, which is 29521.99% up from last year.
  • Latest data reveals that Roivant Sciences reported Non-cash Items of $113.0 million as of Q2 2025, which was up 794.34% from $384.0 million recorded in Q1 2025.
  • Roivant Sciences' Non-cash Items' 5-year high stood at $499.5 million during Q1 2024, with a 5-year trough of $1.9 million in Q1 2022.
  • In the last 4 years, Roivant Sciences' Non-cash Items had a median value of $104.7 million in 2024 and averaged $151.4 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first skyrocketed by 1465360.72% in 2023, then tumbled by 2311.99% in 2025.
  • Quarter analysis of 4 years shows Roivant Sciences' Non-cash Items stood at $55.6 million in 2022, then surged by 64.78% to $91.7 million in 2023, then rose by 17.24% to $107.5 million in 2024, then grew by 5.16% to $113.0 million in 2025.
  • Its Non-cash Items was $113.0 million in Q2 2025, compared to $384.0 million in Q1 2025 and $107.5 million in Q4 2024.